Expression of collagen type I, II, X and Ki-67 in osteochondroma compared to human growth plate cartilage

European Journal of Histochemistry

Volumn 46, Issue 3, 2002, Pages 249-258

  Huch, K ^a   Mordstein, V ^a   Stovel J ^a   Nerlich, A G ^b   Arnholdt, H ^c   Delling, G ^d   Puhl, W ^a   Gunther K P ^a   Brenner, R E ^a  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c KLINIKUM AUGSBURG   (Germany)

^d UNIVERSITY OF HAMBURG   (Germany)

Author keywords

Collagen; Immunohistochemistry; Ki 67; Multiple exostoses; Osteochondroma

Indexed keywords

BIOLOGICAL MARKER; COLLAGEN TYPE 1; COLLAGEN TYPE 10; COLLAGEN TYPE 2; KI 67 ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENCHONDRAL OSSIFICATION; FEMALE; FETUS; FETUS DEVELOPMENT; GROWTH PLATE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; MALE; NEWBORN; OSTEOCHONDROMA; POSTNATAL DEVELOPMENT; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TRABECULAR BONE;

TRABECULA;

EID: 0037648565     PISSN: 1121760X     EISSN: None     Source Type: Journal    
DOI: 10.4081/1687     Document Type: Article

References (32)

1. Ahn J., Ludecke H.J., Lindow S., Horton W.A., Lee B., Wagner M.J., Horsthemke B., and Wells D.E.: Cloning of the putative tumour suppressor gene for hereditary multiple exostoses (EXT1). Nat. Genet. 11, 137-143, 1995.
2. Aigner T., Frischholz S., Dertinger S., Beier F., Girkontaité I., and von der Mark K.: Type X collagen expression and hypertrophic differentiation in chondrogenic neoplasias. Histochem Cell Biol. 107, 435-440, 1997.
3. Allard S.A., Bayliss M.T., and Maini R.N.: The synovium-cartilage junction of the normal human knee. Implications for joint destruction and repair. Arthritis Rheum. 33, 1170-1179, 1990.
4. Apte S.S., and Athanasou N.A.: An immunohistological study of cartilage and synovium in primary synovial chondromatosis. J. Pathol. 166, 277-281, 1992.
5. Apte S.S.: Expression of the cell proliferation-associated nuclear antigen reactive with the Ki-67 monoclonal antibody by cells of the skeletal system in humans and other species. Bone Miner. 10, 37-50, 1990.
6. Bellaiche Y., The I., and Perrimon N.: Tout-velu is a Drosophila homologue of the putative tumour suppressor EXT-1 and is needed for Hh diffusion. Nature 394(6688), 85-88, 1998.
7. Boos N., Nerlich A.G., Wiest I., von der Mark K., Ganz R., and Aebi M.: Immunohistochemical analysis of type X-collagen expression in osteoarthritis of the hip joint. J. Orthop. Res. 17, 495-502, 1999.
8. Bovée J.V., Cleton-Jansen A.M., Wuyts W., Caethoven G., Taminiau A.H., Bakker E., Van Hul W., Cornelisse C.J., and Hogendoorn P.C.: EXT-mutation analysis and loss of heterozygosity in sporadic and hereditary osteochondromas and secondary chondrosarcomas. Am. J. Hum. Genet. 65, 689-698, 1999.
9. Cook A., Raskind W., Blanton S.H., Pauli R.M., Gregg R.G., Francomano C.A., Puffenberger E., Conrad E.U., Schmale G., Schellenberg G., Wijsman E., Hecht J.T., Wells D., and Wagner M.J.: Genetic heterogeneity in families with hereditary multiple exostoses. Am. J. Hum. Genet. 53, 71-79, 1993.
10. rd ed, Thomas, Springfield, IL, pp 17-28, 1978.
11. Davis R.I., Foster H., Arthur K., Trewin S., Hamilton P.W., and Biggart D.J.: Cell proliferation studies in primary synovial chondromatosis. J. Pathol. 184, 18-23 1998.
12. Girkontaité I., Frischholz S., Lammi P., Wagner K., Swoboda B., Aigner T., and von der Mark K.: Immunolocalization of type X collagen in normal fetal and adult osteoarthritic cartilage with monoclonal antibodies. Matrix Biol. 15, 231-238, 1996.
13. Huvos A.G.: Bone tumors. Diagnosis, tretment, and prognosis. WB Saunders Co., Philadelphia, 253-293, 1991.
14. Le Merrer M., Legeai-Mallet L., Jeannin P.M., Horsthemke B., Schinzel A., Plauchu H., Toutain A., Achard F., Munnich A., and Maroteaux P.: A gene for hereditary multiple exostoses maps to chromosome 19p. Hum Mol Genet 3, 717-722, 1994.
15. Legeai-Mallet L., Rossi A., Benoist-Lasselin C., Piazza R., Mallet J.F., Delezoide A.L., Munnich A., Bonaventure J., and Zylberberg L.: EXT 1 gene mutation induces chondrocyte cytoskeletal abnormalities and defective collagen expression in the exostoses. J. Bone Miner. Res. 15, 1489-1500, 2000.
16. Lind T., Tufaro F., McCormick C., Lindahl U., and Lidholt K.: The putative tumor suppressors EXT1 and EXT2 are glycosyltransferases required for the biosynthesis of heparan sulfate. J. Biol. Chem. 273, 26265-26268, 1998.
17. McCormick C., Duncan G., Goutsos K.T., and Tufaro F.: The putative tumor suppressors EXT1 and EXT2 form a stable complex that accumulates in the Golgi apparatus and catalyzes the synthesis of heparan sulfate. Proc. Natl. Acad. Sci. USA 97, 668-673, 2000.
18. McCormick C., Leduc Y., Martindale D., Mattison K., Esford L.E., Dyer A.P., and Tufaro F.: The putative tumour suppressor EXT1 alters the expression of cell-surface heparan sulfate. Nat. Genet. 19, 158-161, 1998.
19. Mirra J.M.: Bone tumors: diagnosis and treatment. Lippincott JB, Philadelphia, pp 520-532, 1980.
20. Nerlich A.G., Schleicher E.D., and Boos N.: 1997 Volvo Award winner in basic science studies. Immunohistologic markers for age-related changes of human lumbar intervertebral discs. Spine 22, 2781-1795, 1997.
21. Pfander D., Rahmanzadeh R., and Scheller E.E.: Presence and distribution of collagen II, collagen I, fibronectin, and tenascin in rabbit normal and osteoarthritic cartilage. J. Rheumatol. 26, 386-394, 1999.
22. Porter D.E., and Simpson A.H.R.W.: The neoplastic pathogenesis of solitary and multiple osteochondromas. J. Pathol. 188, 119-125, 1999.
23. Scarborough M.T., and Moreau G.: Benign cartilage tumors. Ped. Orthop. Oncology 27, 583-589, 1996.
24. Scotlandi K., Serra M., Manara C., Maurici D., Benini S., Nini G., Campanacci M., and Baldini N.: Clinical relevance of Ki-67 expression in bone tumors. Cancer 75, 806-814, 1995.
25. Solomon L.: Hereditary multiple exostosis. Am. J. Hum. Genet. 16, 351-363, 1964.
26. Stenzel I., Pösl M., Ritzel H., Hentz M., Werner M., and Delling G.: Zellproliferation bei Knochentumoren. Immunhistologische Untersuchung zur Ki-67-Protein expression. Pathologe 17, 56-62, 1996.
27. Stickens D., Brown D., and Evans G.A.: EXT genes are differentially expressed in bone and cartilage during mouse embryogenesis. Dev. Dyn. 218, 452-64, 2000.
28. von der Mark K.: Localization of collagen types in tissues. Int. Rev. Connect Tissue Res. 9, 265-324, 1981.
29. Wu Y.Q., Heutink P., de Vries B.B., Sandkuijl L.A., van den Ouweland A.M., Niermeijer M.F., Galjaard H., Reyniers E., Willems P.J., and Halley D.J.: Assignment of a second locus for multiple exostoses to the pericentromeric region of chromosome 11. Hum. Mol. Genet. 3, 167-171, 1994.
30. Wuyts W., Van Hul W., De Boulle K., Hendrickx J., Bakker E., Vanhoenacker F., Mollica F., Ludecke H.J., Sayli B.S., Pazzaglia U.E., Mortier G., Hamel B., Conrad E.U., Matsushita M., Raskind W.H., and Willems P.J.: Mutations in the EXT1 and EXT2 genes in hereditary multiple exostoses. Am. J. Hum. Genet. 62, 346-354, 1998.
31. Wuyts W., Van Hul W., Wauters J., Nemtsova M., Reyniers E., Van Hul E.V., De Boulle K., de Vries B.B., Hendrickx J., Herrygers I., Bossuyt P., Balemans W., Fransen E., Vits L., Coucke P., Nowak N.J., Shows T.B., Mallet L., van den Ouweland A.M., McGaughran J., Halley D.J., and Willems P.J.: Positional cloning of a gene involved in hereditary multiple exostoses. Hum. Mol. Genet. 5, 1547-1557, 1996.
32. Wuyts W., and Van Hul W.: Molecular basis of multiple exostoses: mutations in the EXT1 and EXT2 genes. Hum. Mutat. 15, 220-227, 2000.